MCKESSON CORP MCK
NYSE · XNYS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 1994-11-10
MCKESSON CORP financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $403.4B | $359.1B | $309.0B | $276.7B | $264.0B |
| Gross profit | $14.6B | $13.3B | $12.8B | $12.4B | $13.1B |
| SG&A expense | $8.1B | $8.5B | $8.7B | $7.8B | $10.5B |
| Operating income | $6.2B | $4.4B | $3.9B | $4.4B | $2.0B |
| Interest expense | — | — | $252.0M | $248.0M | $178.0M |
| Income tax | $1.1B | $878.0M | $629.0M | $905.0M | $636.0M |
| Net income | $4.8B | $3.3B | $3.0B | $3.6B | $1.1B |
| EPS (diluted) | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 |
| Operating cash flow | $6.2B | $6.1B | $4.3B | $5.2B | $4.4B |
| Free cash flow | $5.7B | $5.5B | $3.9B | $4.8B | $4.0B |
| Cash & equivalents | $4.0B | $5.7B | $4.6B | $4.7B | $3.5B |
| Inventory | $24.2B | $23.0B | $21.1B | $19.7B | $18.7B |
| Total assets | $82.3B | $75.1B | $67.4B | $62.3B | $63.3B |
| Shareholders' equity | -$2.2B | -$2.1B | -$2.0B | -$1.9B | -$2.3B |
Source: SEC EDGAR filings · CIK 0000927653 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.